Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas - a Randomized Controlled Trial

NCT03916003 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT03916003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas - a Randomized Controlled Trial
Lead sponsor
Menzies School of Health Research
Phase
Phase 4
Overall status
Completed
Start date
August 18, 2019
Completion date
July 30, 2022
Enrollment
500 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

falciparum malaria, malaria, vivax malaria